Menu
Live News EQUITY M impact

QURE: Reports Prelim Data

uniQure announces preliminary data on the first cohort in the Phase I/IIa clinical trial of AMT-260 in refractory mesial temporal lobe epilepsy

QURE

QURE - uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy